Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial (Q35572535)
Jump to navigation
Jump to search
scientific article published on 3 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial |
scientific article published on 3 March 2015 |
Statements
1 reference
Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial (English)
1 reference
Nicolas Van As
1 reference
Karim Fizazi
1 reference
Nadine Houede
1 reference
Cora N Sternberg
1 reference
Daniel P Petrylak
1 reference
Nicholas J Vogelzang
1 reference
Nikolay Budnik
1 reference
Pawel Jan Wiechno
1 reference
Kevin Doner
1 reference
Joaquim Bellmunt
1 reference
John M Burke
1 reference
Maria Ochoa de Olza
1 reference
Juergen E Gschwend
1 reference
Evgeny Kopyltsov
1 reference
Aude Flechon
1 reference
Debora Barton
1 reference
Abderrahim Fandi
1 reference
Ulf Jungnelius
1 reference
Shaoyi Li
1 reference
Ronald de Wit
1 reference
3 March 2015
1 reference
1 reference
16
1 reference
4
1 reference
417-425
1 reference
Identifiers
1 reference
1 reference